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A Higher Burden of Small Low-density Lipoprotein Particles is 
Associated with Profound Changes in the Free Androgen Index 
in Male Adolescents 
From a young age, males are at higher cardiovascular risk than females. Dyslipidemia, 
including a higher burden related to small low-density lipoproteins (LDL), plays an 
important role in precipitating atherosclerosis in both males and females. We investigated 
sex differences in atherogenic lipoprotein burden and the independent predictors of LDL 
particle size in children and adolescents. We measured the concentrations of total 
testosterone, sex hormone-binding globulin, estradiol, total cholesterol, triglyceride, LDL 
cholesterol, HDL cholesterol, and LDL particle size in 135 children and adolescents  
(67 boys, 68 girls). The free androgen index was significantly and negatively correlated 
with LDL particle size (r = –0.273, P = 0.026) in boys, but estrogen and LDL particle size 
were not related. In a stepwise multiple regression analysis adjusted for body mass index, 
age, and homeostasis model assessment for insulin resistance, free androgen index was still 
an independent predictor of LDL particle size in boys (R
2 = 0.075, P = 0.026). 
The prominent decrease in LDL particle size along with increased testosterone 
concentrations in males might explain why they are more likely to display atherogenic 
dyslipidemia from adolescence.
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INTRODUCTION
Plasma low-density lipoprotein cholesterol (LDL-C) is associat-
ed with an increased risk of coronary heart disease (CHD) (1, 2); 
however, more than 30% of patients with CHD events have nor-
mal LDL-C level (3, 4). LDL particles are heterogeneous and can 
be divided into two subclasses based on variations in density, 
size, and chemical composition: large buoyant LDL (lb-LDL, 
pattern A) and small dense LDL (sd-LDL, pattern B) (5). Stud-
ies have shown that sd-LDL has greater atherogenic potential 
than lb-LDL in various ethnic groups (6-9).  
  Several studies have reported that LDL particle size tends to 
be smaller in both young and adult males compared to females 
(10-12). Hormonal differences have been hypothesized to ac-
count for these sex differences, but few studies have examined 
the association between sex steroid hormones and LDL particle 
size in young people. A recent clinical trial showed that hormone 
replacement therapy (HT) does not reduce the risk of coronary 
disease in postmenopausal women (13). Furthermore, HT users 
reportedly do not have a better LDL subclass distribution, which 
may explain the failure of HT to reduce the incidence of heart 
disease events (14). These results suggest that estrogens might 
not be the key determinant of this sex difference.
  Children and adolescents experience profound changes in 
sex steroid hormones during puberty. Moreover, adverse pat-
terns of atherosclerosis begin during childhood (15). Therefore, 
children and adolescents are appropriate candidates to study 
the relationship between sex steroid hormones and LDL size.
  The purpose of this study was to compare LDL particle size in 
boys and girls, and to investigate whether changes in male sex 
hormone concentrations are related to LDL particle size in chil-
dren and adolescents.Choi YJ, et al.  •  Sex Differences in LDL Particle Size in Children and Adolescents
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MATERIALS AND METHODS
A detailed description of the study design and methods is out-
lined in a previous report (16). Briefly, 135 children and adoles-
cents (67 boys, 68 girls; mean age, 11.6 ± 2.0 yr) participated after 
guardians’ permission in this study from January to February in 
2004; their ages ranged from 7 to 16 yr. The subjects were recruit-
ed through newspaper advertisements in Suwon, Korea. Puber-
tal stage was assessed by physical examination, which was per-
formed by a pediatrician at our institute, according to the Tan-
ner criteria. We assigned 33 boys and 19 girls to the child group 
(Tanner stage = 1) and 34 boys and 49 girls to the adolescent 
group (Tanner stage ≥ 2). 
Anthropometric and body fat measurements
We measured the weight and height of all subjects in the morn-
ing after minimum 8-hr fasting while they were wearing light 
clothing. Body mass index (BMI) was calculated as weight (kg)/
height (m
2). Blood pressure was measured twice in the sitting po-
sition at 3-min intervals using a standard sphygmomanometer.
  To assess the distribution of body fat in the abdomen, we per-
formed computed tomography (High Speed Advantage; General 
Electric Co., Fairfield, CT, USA) at the umbilical level and mea-
sured the total abdominal fat area (cm
2) equivalent to a Houn-
sfield unit range of -50 to -250. We identified the visceral fat area 
and subcutaneous fat area by applying the peritoneum as a bound-
ary. The clinical status of the participants was made unknown 
to the investigator who collected and analyzed these data.
Laboratory measurements
After fasting for 8 hr or more, all subjects visited laboratory be-
tween 08:00 and 10:00, and a blood sample was drawn from the 
antecubital vein. Plasma was separated from the collected blood 
and stored at -70°C until analyzed. Glucose, insulin, total cho-
lesterol, triglyceride (TG), and high-density lipoprotein (HDL)-
cholesterol concentrations were measured by standard meth-
ods. LDL-C concentration was calculated using the Friedewald 
equation. As a marker of insulin resistance, a homeostasis mod-
el assessment (HOMA) index was calculated from the fasting 
insulin and glucose concentrations as (insulin [μIU/mL] × glu-
cose [mM/L])/22.5.
  Estradiol (E2) and total testosterone concentrations were mea-
sured with commercial solid-phase radioimmunoassays (Diag-
nostic Products Corp., Los Angeles, CA, USA). Sex hormone-
binding globulin (SHBG) concentrations were measured using 
a commercial immunoradiometric assay (Diagnostic Products 
Corp.). The free androgen index (FAI) was used to estimate the 
amount of testosterone unbound by SHBG and thus, immedi-
ately biologically active. FAI was calculated as (100 Total testos-
terone/SHBG). To convert testosterone to nM, the ng per mL 
value was multiplied by 3.467.
  LDL particles were isolated by sequential flotation ultracen-
trifugation, and LDL particle size distribution (d 1.019-1.063 g/
mL) was examined using a pore gradient lipoprotein system 
(CBS Scientific, Del Mar, CA, USA) with commercially available 
non-denaturing polyacrylamide slab gels containing a linear 
gradient of 2% to 16% acrylamide (Alamo Gels Inc., San Anto-
nio, TX, USA). Standards, including latex beads (34 nm), thyro-
globulin (17 nm), apoferritin (12.2 nm), and catalase (10.4 nm), 
were used to estimate the relative migration (Rf) rates of each 
band. The gels were scanned using a GS-800 Calibrated Imaging 
Densitometer (Bio-Rad Laboratories, Graz, Austria). LDL parti-
cle size was calculated with reference to the Rf value of the stan-
dards. LDL subclasses were classified as sd-LDL (pattern B; diam-
eter < 25.5 nm) and lb-LDL (pattern A; diameter < 25.5 nm) (5).
Statistical analysis
The subjects were divided into two groups based on the Tanner 
stage: children (Tanner stage = 1) and adolescents (Tanner stage 
≥ 2). In each group, boys and girls were analyzed separately to 
better understand the association between LDL particle size and 
sex steroid hormone concentrations. All data are presented as 
means ± standard deviation and number. Since HOMA for in-
sulin resistance (IR) and concentrations of insulin, TG, testos-
terone, SHBG, FAI, and E2 were not normally distributed, these 
variables were log-transformed prior to analysis.
  The clinical characteristics and laboratory findings were com-
pared for boys and girls using Student’s t test. Because BMI and 
age differed significantly between boys and girls in both children 
and adolescents, each factor was compared using an ANCOVA 
after adjusting for BMI and age. We used correlation analyses to 
examine the relationship between LDL particle size and each 
factor in boys and girls, separately. Multiple stepwise regression 
analysis was performed to investigate whether the FAI was re-
lated to LDL particle size in boys, after adjusting for age, BMI, 
and HOMA-IR.
  Statistical analyses were performed using PASW for Windows 
(v. 18.0; SPSS Inc., Chicago, IL, USA), and P < 0.05 was consid-
ered significant.
Ethics statement
This study was conducted according to the ethical guidelines of 
Ajou University Hospital and Ajou University School of Medi-
cine and written informed consent was obtained from all guard-
ians of the participants.
 
RESULTS
Sex differences in baseline characteristics and LDL 
particle size in children and adolescents
Table 1 shows the data for clinical and biochemical parameters 
and LDL particle size grouped by sex in children and adolescents. Choi YJ, et al.  •  Sex Differences in LDL Particle Size in Children and Adolescents
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Boys were older than girls in both the child (P = 0.013) and ado-
lescent groups (P = 0.021). No significant sex difference in Tan-
ner stage existed within adolescents. Systolic blood pressure 
(SBP) was significantly higher in boys for both children (P = 0.035) 
and adolescents (P < 0.001). BMI differed significantly between 
boys and girls, and was higher in both groups of boys (P = 0.002 
for children, P < 0.001 for adolescents). Visceral fat area was sig-
nificantly higher in boys of both groups (P = 0.002 for children, 
P = 0.022 for adolescents), although the subcutaneous fat area 
was significantly higher only in male children (P = 0.023). FAI 
and serum testosterone concentrations were significantly higher 
in boys for both children (P = 0.002) and adolescents (P < 0.001). 
SHBG and E2 concentrations were significantly higher in girls 
than in boys, but only for adolescents (P < 0.001).
  The concentrations of total cholesterol, HDL-C, LDL-C, and 
TG did not differ significantly between boys and girls in either 
age group. Of note, LDL particle size did not differ between the 
sexes in children, but was significantly smaller in male adoles-
cents as compared to female adolescents (P = 0.012). After ad-
justing for BMI and age, the difference between sexes was still 
significant for SBP in both age groups (P < 0.05). In adolescents, 
the serum concentrations of testosterone, SHBG, and E2, and 
LDL particle size remained significantly different after adjust-
ment (P < 0.05). However, FAI and serum testosterone concen-
Table 1. Comparison of clinical and biochemical parameters and LDL particle size by sex in children and adolescents
Parameters
Children Adolescents
Boys Girls P Boys Girls P
Number 33 19  -  34  49  - 
Age (yr)  10.5 ± 1.4    9.4 ± 1.3  0.013  13.1 ± 1.4    12.3 ± 1.7     0.021 
BMI (kg/m
2)  20.7 ± 4.2  17.0 ± 3.3  0.002  22.9 ± 3.3    20.2 ± 3.2  < 0.001 
Tanner stage  1  1  ns    3.0 ± 1.2      3.4 ± 1.2  ns 
SBP (mmHg)  110.0 ± 10.6  103.2 ± 11.1  0.035  113.6 ± 10.1  100.6 ± 9.2  < 0.001 
DBP (mmHg)  70.7 ± 8.1  66.3 ± 7.6  ns  73.2 ± 7.3    63.3 ± 6.6  < 0.001 
Total abdominal fat (cm
2)   164.6 ± 100.2  100.2 ± 71.8   0.014
†    192.8 ± 110.6    148.4 ± 76.0       0.047
†
Visceral fat (cm
2)    39.7 ± 23.3    23.2 ± 12.6   0.002
†    41.2 ± 22.3      31.0 ± 13.8       0.022
† 
Subcutaneous fat (cm
2) 124.9 ± 76.6    77.1 ± 59.9  0.023  151.6 ± 91.9    117.4 ± 66.6  ns 
HOMA-IR*    1.1 ± 1.0    0.8 ± 0.8  ns    1.7 ± 1.3      1.8 ± 1.2  ns 
Total cholesterol (mg/dL)  168.4 ± 25.4  168.9 ± 25.3  ns  160.6 ± 33.2    161.1 ± 24.1  ns 
Triglycerides (mg/dL)*    92.8 ± 56.6    75.7 ± 55.6  ns  112.1 ± 67.1      89.9 ± 59.4  ns 
HDL-C (mg/dL)    53.0 ± 11.5    58.3 ± 17.4  ns    49.7 ± 14.7      53.0 ± 10.0  ns 
LDL-C (mg/dL)    96.8 ± 20.2    95.5 ± 20.6  ns    88.5 ± 24.6      90.1 ± 20.0  ns 
Testosterone (ng/mL)*    0.43 ± 1.18    0.04 ± 0.01   0.001
†    2.88 ± 1.71      0.20 ± 0.13  < 0.001 
SHBG (nM/L)*    63.1 ± 24.7    79.1 ± 34.1  ns    34.6 ± 23.0      57.4 ± 26.5  < 0.001 
FAI*   3.0 ± 7.4   0.3 ± 0.4  0.002
†   38.6 ± 25.6     1.7 ± 1.9 < 0.001
E2 (pg/mL)*  12.9 ± 3.8  12.5 ± 5.1  ns  21.1 ± 8.9      46.4 ± 46.2  < 0.001 
LDL size (nm)  26.8 ± 0.8  26.9 ± 0.7  ns  26.6 ± 0.8    27.1 ± 0.7     0.012 
Data are presented as means ± SD; P values by Student’s t-test for continuous variables and χ2 tests for categorical variables are given. *log-transformed; 
†not significant after 
adjustment for BMI and age by ANCOVA. BMI, body mass index; HOMA-IR, homeostasis model assessment for insulin resistance; HDL-C, high density lipoprotein cholesterol; 
LDL-C, low density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; SHBG, sex hormone-binding globulin; FAI, free androgen index; E2, estradiol; 
LDL, low density lipoprotein; ns, not significant.
Fig. 1. Correlation between low density lipoprotein (LDL) particle size and sex hormones in children (A) and adolescents (B).
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trations were not significantly different in children after adjust-
ment.  
Correlation between sex hormones and LDL particle size 
in boys and girls
In boys, univariate analysis showed significant associations be-
tween LDL particle size and BMI, SBP, DBP, TG, HDL-C, testos-
terone, SHBG, and FAI (P < 0.05). In girls, only TG and HDL-C 
were significantly associated with LDL particle size (P < 0.05); 
none of sex hormones were associated with LDL particle size. 
The relationships between LDL size and sex hormones in boys 
and girls are shown in Fig. 1. 
  Because LDL particle size was significantly associated with 
FAI only in boys, we performed the stepwise multivariable re-
gression analysis in boys only. Since age, BMI, and HOMA-IR 
were significantly associated with FAI (data not shown), these 
parameters were defined as confounding variables in the anal-
ysis. As a result, FAI remained an independent predictor of LDL 
particle size in boys (R
2 = 0.075, P = 0.026).  
LDL particle size before and after puberty in relation to 
sex hormone concentrations
LDL particle size was significantly different only in adolescents, 
not in children (Table 1), and FAI was independently correlated 
with LDL particle size only in boys. E2 concentration and LDL 
particle size were not significantly correlated in either age group 
(Table 2). We hypothesized that LDL particle size is affected by 
more profound changes in testosterone concentrations. To test 
this hypothesis, we categorized individuals as either before or 
after puberty in both boys and girls according to their testoster-
one and E2 concentrations, respectively. We arbitrarily deter-
mined a cutoff level as the prepubertal upper normal values of 
testosterone (0.8 nM/L) and E2 (10 pg/mL) concentrations and 
lower normal value of SHBG (62.4 nM/L) concentrations (17). 
We also calculated the FAI cutoff value (1.28) using the arbitrari-
ly determined testosterone and SHBG concentrations. The anal-
ysis showed that LDL particle size differed significantly before 
and after puberty (P = 0.025) in boys, but not in girls (P = 0.982) 
(Fig. 2).
 
DISCUSSION
In this study, we showed that LDL particle size was significantly 
smaller only in adolescents, and that the particle size decreases 
as FAI increases in boys. Even though LDL-C concentrations were 
within the normal range and did not differ between boys and 
girls in children and adolescents, the higher burden of small 
dense LDL during puberty in boys could imply a higher cardio-
vascular risk in males starting at a young age.
  The factors affecting LDL particle size have been studied wide-
ly in adults, but few studies have included children (12, 18-20). 
Among these factors, sex has been suggested to be important, 
although few studies have found sex differences in LDL size in 
children (12, 21). In contrast, some investigations of adults have 
reported significant sex differences in LDL size (10, 11). These 
studies found larger LDL particle sizes in women, and our re-
sults extend this previously reported sex difference to include 
children and adolescents.
  The mechanisms responsible for the sex differences in LDL 
particle size remain unclear. Studies have suggested that differ-
ences in visceral fat accumulation and TG metabolism between 
men and women are responsible for this sex difference (10-12). 
However, we found no sex differences in visceral fat or TG con-
centrations in either age group. In addition, we found no associ-
ation between visceral fat and LDL particle size in boys and girls.  
  The relationship between testosterone concentrations and 
Table 2. Anthropometric and biochemical parameters associated with LDL particle 
size in boys and girls
Parameters
Boys  Girls
r  P  r  P 
Age (yr)  -0.177 ns 0.054 ns
BMI (kg/m
2)  -0.271 0.027 -0.032 ns
SBP (mm Hg)  -0.309 0.013 -0.031 ns
DBP (mm Hg)  -0.273 0.029 -0.046 ns
Total body fat (cm
2)  -0.151 ns -0.031 ns
Visceral fat (cm
2)  -0.143 ns -0.141 ns
Subcutaneous fat (cm
2)  -0.146 ns -0.007 ns
Total cholesterol (mg/dL)  -0.034 ns -0.176 ns
Triglycerides (mg/dL)*  -0.534 < 0.001 -0.547 < 0.001
HDL-C (mg/dL)  0.442 < 0.001 0.340 0.006
LDL-C (mg/dL)  0.024 ns -0.098 ns
HOMA-IR*  -0.147 ns -0.170 ns
Testosterone (ng/mL)* -0.249 0.044 0.077 ns
SHBG (nM/L)* 0.255 0.039 0.154 ns
FAI* -0.273 0.026 -0.017 ns
E2 (pg/mL)* -0.226 ns 0.058 ns
*log-transformed. r, correlation coefficient; BMI, body mass index; SBP, systolic blood 
pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; 
LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment 
for insulin resistance; SHBG, sex hormone-binding globulin; FAI, free androgen index; 
E2, estradiol; ns, not significant. 
Fig. 2. Mean low density lipoprotein (LDL) particle size before and after mid-puberty 
in boys and girls according to testosterone and estrogen levels, respectively. 
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the lipid profile is controversial. Few studies have examined the 
association between LDL particle size and testosterone concen-
tration. In one adult study, low levels of SHBG and testosterone 
were associated with small dense LDL in normoglycemic mid-
dle-aged men (22). These data are inconsistent with our results. 
However, testosterone administration in men decreased LDL 
size in other studies (23, 24). In vivo studies found that testoster-
one administration increases the activity of hepatic lipase, which 
hydrolyzes TG in LDL and produces small dense LDL particles. 
This mechanism may explain why testosterone is associated 
with smaller LDL particle size (23-25).
  In this study, we found a difference in LDL particle size only 
in adolescents and not in children. Moreover, FAI was associat-
ed with LDL particle size only in boys. This led us to hypothesize 
that some threshold in testosterone concentration must be reached 
for this association. To test this hypothesis, we compared LDL 
particle size before and after puberty according to sex hormone 
concentrations and found a significant difference between the 
two groups, but only in boys. These results were consistent with 
the hypothesis that testosterone had a more potent effect on 
LDL particle size than estrogen, and that profound changes in 
testosterone concentration were involved in the regulation of 
LDL particle size. 
  In general, estrogen has been regarded as a favorable factor 
on lipid profiles and anti-atherogenic effects, and is one of the 
factors responsible for the sex difference in cardiovascular risk 
(26). However, the Women’s Health Initiative clinical trial failed 
to find a reduction in coronary heart disease events among es-
trogen HT users (13). They also found that HT users did not have 
a better LDL subclass distribution, which may explain the fail-
ure of HT to reduce the incidence of heart disease events (14). 
Furthermore, the SWAN study reported that FAI was related to 
cardiovascular risk factors, including unfavorable lipid profiles 
in multiethnic premenopausal and perimenopausal women 
(27). Based on our results and the reasons cited above, we sug-
gest that testosterone might have a greater effect on LDL parti-
cle size than estrogen. More studies are required to confirm this 
conclusion.
  This study has several limitations. First, the study was per-
formed on a small number of subjects and thus did not repre-
sent all children and adolescents in the population. In addition, 
the study design was cross-sectional, and therefore, we cannot 
speculate on the association between LDL particle size and se-
rial changes in FAI. Specifically, we cannot evaluate the longitu-
dinal association between testosterone concentrations and LDL 
particle size before and after puberty in the same individuals. 
However, we could estimate longitudinal associations from this 
study, including a broad spectrum of ages from prepuberty to 
late puberty. In this study, we could not measure free testoster-
one, which is more informative as a male sex hormone. FAI is 
also known to have a poor correlation with actual free testoster-
one concentrations in male adults (28, 29). However, free testos-
terone can be approximated by FAI if, and only if, the total tes-
tosterone concentration is negligible in relation to the concentra-
tions of SHBG-binding sites (28). For that reason, this is a reason-
able approximation for samples from children in whom blood 
testosterone concentrations are rarely above 10% of the SHBG 
concentration (29). In addition, we could not draw blood at the 
same point in the menstrual cycle in girls. Given the variation 
in serum estradiol concentrations over the menstrual cycle, 
whether estradiol concentrations are associated with LDL par-
ticle size is not clear. Further studies are required to elucidate 
the association between estrogen and LDL particle size in chil-
dren and adolescents.  
  Our study, however, is the first to show that FAI is significant-
ly related to LDL particle size in boys, and our findings suggest 
that testosterone might contribute to higher cardiovascular risk 
in males by lowering LDL particle size. Further prospective stud-
ies should focus on the effects of sex hormones on the lipid pro-
file and the associated development of atherosclerosis.
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Even from a young age, males are known to have higher cardiovascular risk than females. Dyslipidemia, including a higher burden 
related to small low-density lipoproteins (LDL), plays an important role in precipitating atherosclerosis. Here we investigate sex 
differences in atherogenic lipoprotein burden and the LDL particle size in 135 children and adolescents. LDL particle size is 
significantly smaller in male than female. The free androgen index (FAI) (100 Total testosterone/sex hormone binding globulin 
[SHBG]) is negatively correlated with LDL particle size in boys whereas estrogen and LDL particle size are not related with each 
other. After puberty, LDL particle size declines markedly in male adolescents. The prominent decrease in LDL particle size associated 
with an increase in testosterone concentrations might underlie the risk of atherogenic dyslipidemia in males from adolescence.